![](media/image1.png){width="5.96875in" height="0.41944444444444445in"}

Top of Form

## Complete Summary

#### GUIDELINE TITLE

Guidelines for pediatric cancer centers.

#### BIBLIOGRAPHIC SOURCE(S)

Corrigan JJ, Feig SA. Guidelines for pediatric cancer centers.
Pediatrics 2004 Jun;113(6):1833-5. \[10 references\]
[PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15173520)

#### GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years
by the authoring body, at which time a recommendation is made that the
policy be retired, revised, or reaffirmed without change. Until the
Board of Directors approves a revision or reaffirmation, or retires a
statement, the current policy remains in effect.

### COMPLETE SUMMARY CONTENT

 SCOPE\
 METHODOLOGY - including Rating Scheme and Cost Analysis\
 RECOMMENDATIONS\
 EVIDENCE SUPPORTING THE RECOMMENDATIONS\
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS\
 IMPLEMENTATION OF THE GUIDELINE\
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT
CATEGORIES\
 IDENTIFYING INFORMATION AND AVAILABILITY\
 DISCLAIMER

### SCOPE

#### DISEASE/CONDITION(S)

Pediatric cancer

#### GUIDELINE CATEGORY

Management\
Treatment

#### CLINICAL SPECIALTY

Family Practice\
Hematology\
Internal Medicine\
Neurological Surgery\
Neurology\
Oncology\
Orthopedic Surgery\
Pathology\
Pediatrics\
Radiation Oncology\
Radiology\
Surgery\
Urology

#### INTENDED USERS

Advanced Practice Nurses\
Allied Health Personnel\
Managed Care Organizations\
Pharmacists\
Physician Assistants\
Physicians\
Social Workers

#### GUIDELINE OBJECTIVE(S)

To delineate personnel and facilities that are essential to provide
state-of-the-art care for children and adolescents with cancer

#### TARGET POPULATION

Children and adolescents with cancer

#### INTERVENTIONS AND PRACTICES CONSIDERED

Referral of pediatric and adolescent cancer patients to a pediatric
cancer care center with appropriate personnel, facilities, and
capabilities

#### MAJOR OUTCOMES CONSIDERED

Effectiveness of pediatric cancer centers in treating children and
adolescents with cancer

### METHODOLOGY

#### METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

#### DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

Not stated

#### NUMBER OF SOURCE DOCUMENTS

Not stated

#### METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Not stated

#### RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not applicable

#### METHODS USED TO ANALYZE THE EVIDENCE

Review

#### DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

Not stated

#### METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus

#### DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

Not stated

#### RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

#### COST ANALYSIS

A formal cost analysis was not performed and published cost analyses
were not reviewed.

#### METHOD OF GUIDELINE VALIDATION

Peer Review

#### DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

Not stated

### RECOMMENDATIONS

#### MAJOR RECOMMENDATIONS

On the basis of the effectiveness of pediatric cancer centers in
treating children and adolescents with cancer, the American Academy of
Pediatrics recommends the following:

-   Children and adolescents with newly suspected and/or recurrent
    malignancy should be referred to a pediatric cancer center for
    prompt and accurate diagnosis and management.

-   Children and adolescents with newly diagnosed and/or recurrent
    malignancies should have their treatment coordinated by a
    board-certified pediatric hematologist/oncologist; treatment should
    be prescribed and initiated at a pediatric cancer center but may be
    continued at a center not specialized in the care of the pediatric
    oncology patient under the continuing oversight of the center´s
    multidisciplinary team.

-   Multidisciplinary team members should have pediatric expertise
    within their specialty area.

The original guideline document also details personnel, facilities, and
capabilities that should be provided in a pediatric oncologic care
center.

#### CLINICAL ALGORITHM(S)

None provided

### EVIDENCE SUPPORTING THE RECOMMENDATIONS

#### TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each
recommendation.

### BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

#### POTENTIAL BENEFITS

The clinical results in children with cancer have been shown to be
superior when specialized diagnostic, supportive, and specific care is
given at a pediatric cancer center.

#### POTENTIAL HARMS

Not stated

### IMPLEMENTATION OF THE GUIDELINE

#### DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

### INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

#### IOM CARE NEED

Getting Better\
Living with Illness

#### IOM DOMAIN

Effectiveness\
Patient-centeredness

### IDENTIFYING INFORMATION AND AVAILABILITY

#### BIBLIOGRAPHIC SOURCE(S)

Corrigan JJ, Feig SA. Guidelines for pediatric cancer centers.
Pediatrics 2004 Jun;113(6):1833-5. \[10 references\]
[PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15173520)

#### ADAPTATION

Not applicable: The guideline was not adapted from another source.

#### DATE RELEASED

2004 Jun

#### GUIDELINE DEVELOPER(S)

American Academy of Pediatrics - Medical Specialty Society

#### SOURCE(S) OF FUNDING

American Academy of Pediatrics

#### GUIDELINE COMMITTEE

Section on Hematology/Oncology

#### COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

*Section on Hematology/Oncology 2003--2004*: Roger L. Berkow, MD,
Chairperson; \*James J. Corrigan, MD; \*Stephen A. Feig, MD; F. Leonard
Johnson, MD; Peter A. Lane, MD; John J. Hutter, Jr, MD

*Liaisons*: Edwin N. Forman, MD, Childhood Cancer Alliance; Naomi L.
Luban, MD, American Association of Blood Banks

*Staff*: Laura Laskosz, MPH

\*Lead authors

#### FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

#### GUIDELINE STATUS

This is the current release of the guideline.

American Academy of Pediatrics (AAP) Policies are reviewed every 3 years
by the authoring body, at which time a recommendation is made that the
policy be retired, revised, or reaffirmed without change. Until the
Board of Directors approves a revision or reaffirmation, or retires a
statement, the current policy remains in effect.

#### GUIDELINE AVAILABILITY

Electronic copies: Available from the [American Academy of Pediatrics
(AAP) Publications Web
site](http://pediatrics.aappublications.org/cgi/content/full/113/6/1833).

Print copies: Available from American Academy of Pediatrics, 141
Northwest Point Blvd., P.O. Box 927, Elk Grove Village, IL 60009-0927.

#### AVAILABILITY OF COMPANION DOCUMENTS

None available

#### PATIENT RESOURCES

None available

#### NGC STATUS

This NGC summary was completed by ECRI on August 9, 2004. The
information was verified by the guideline developer on September 27,
2004.

#### COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to
the guideline developer\'s copyright restrictions. Please contact the
Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest
Point Blvd, Elk Grove Village, IL 60007.

### DISCLAIMER

#### NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce,
approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced
under the auspices of medical specialty societies, relevant professional
associations, public or private organizations, other government
agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline
developers, and are screened solely to determine that they meet the NGC
Inclusion Criteria which may be found at
<http://www.guideline.gov/about/inclusion.aspx> .

NGC, AHRQ, and its contractor ECRI Institute make no warranties
concerning the content or clinical efficacy or effectiveness of the
clinical practice guidelines and related materials represented on this
site. Moreover, the views and opinions of developers or authors of
guidelines represented on this site do not necessarily state or reflect
those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or
hosting of guidelines in NGC may not be used for advertising or
commercial endorsement purposes.

Readers with questions regarding guideline content are directed to
contact the guideline developer.

Bottom of Form

© 1998-2008 National Guideline Clearinghouse

Date Modified: 11/3/2008